Co-Authors
This is a "connection" page, showing publications co-authored by Philippe Ravaud and Xavier Mariette.
Connection Strength
2.087
-
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial. JAMA Intern Med. 2021 09 01; 181(9):1241-1243.
Score: 0.965
-
Tocilizumab in Treatment for Patients With COVID-19-Reply. JAMA Intern Med. 2021 07 01; 181(7):1020-1021.
Score: 0.238
-
Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort. Rheumatology (Oxford). 2020 05 01; 59(5):988-996.
Score: 0.220
-
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Res Ther. 2018 06 08; 20(1):122.
Score: 0.193
-
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum. 2004 Apr; 50(4):1270-6.
Score: 0.072
-
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA. 2021 08 10; 326(6):499-518.
Score: 0.060
-
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 01 01; 181(1):32-40.
Score: 0.058
-
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. BMJ. 2019 Jan 24; 364:l67.
Score: 0.050
-
Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy. Presse Med. 2018 Feb; 47(2):e9-e13.
Score: 0.047
-
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data. Rheumatology (Oxford). 2018 01 01; 57(1):134-139.
Score: 0.047
-
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry. RMD Open. 2017; 3(2):e000515.
Score: 0.046
-
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. Rheumatology (Oxford). 2017 10 01; 56(10):1746-1754.
Score: 0.046
-
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry. Rheumatology (Oxford). 2017 04 01; 56(4):629-637.
Score: 0.044